Switzerland (CH)

Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin (2025) Van Passen C, Krug J, Weiß L, Mohamed Abdou M, Tripal P, Schmid B, Krüger R, et al. Journal article “Did I buy that just now?” – Investigating factors influencing the accuracy of food choice self-reports in a simulated online grocery store (2025) Manzke L, O'Sullivan K, Tiefenbeck V Journal article What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy? (2025) Putora PM, Henke G, Beşe N, Boersma L, Coles CE, de Boniface J, Duane F, et al. Journal article A single specific and actionable swap recommendation can lead to substantial reductions in households’ dietary carbon footprints (2025) O'Sullivan K, Tiefenbeck V, Stucki M, Bradford S, Fuchs KL, Wanner S, Fleisch E Journal article Following Changes at the Solid/Liquid Interface for Large Microplastic Particles by Streaming Potential (2025) Engelhardt M, Wagner D, Zarebanadkouki M, Meides N, Schulbert C, Löder MG, Helfricht N, et al. Journal article Activation mapping in multi-center retrospective rat sensory-evoked functional MRI datasets using a unified pipeline (2025) Galteau ME, Broadwater M, Chen Y, Desrosiers-Gregoire G, Gil R, Käßer J, Kim E, et al. Journal article Pleistocene glacial geomorphology and chronology of the Nahuel Huapi-Limay and Traful catchments, northern Patagonia (2025) Mizerit I, Morabito EG, Bechis F, Terrizzano CM, Groos AR, Rugel G, Merchel S, Zech R Journal article Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD (2025) Chatterjee S, Rückert T, Martin I, Michaeli E, Buescher J, Apostolova P, Erny D, et al. Journal article Hearing rehabilitation in SERAC1 related MEGD(H)EL syndrome – implications from a multi-center retrospective cohort study (2025) Roesch S, O'Sullivan A, Tschani S, Baghdasaryan A, Balasubramaniam S, Barić I, de Boer L, et al. Journal article Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease (2025) Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, et al. Journal article